Investment Rating - The industry investment rating is "Overweight" [1] Core Viewpoints - The Hong Kong Stock Exchange is expected to benefit from the expansion of the asset side, with an increase in trading activity due to leading A-share companies listing in Hong Kong and quality Chinese concept stocks returning to the Hong Kong market [3] - There are signs of relaxation in the private placement of securities firms, with recent approvals for capital increases focusing on supporting the real economy [4] - The insurance sector is likely to see a reduction in liability costs due to the recent decrease in LPR and deposit rates, which may lead to a further decline in the preset interest rates of insurance products [5] Summary by Sections Non-Bank Financial - The report maintains a positive outlook on the non-bank financial sector, highlighting the potential for growth driven by market activity and regulatory support [1][3] Securities Firms - Daily average stock fund transaction volume was 1.31 trillion, down 5.6% week-on-week, but up 50% year-on-year, indicating a robust market despite recent fluctuations [4] - The China Securities Association is developing evaluation methods for securities firms to enhance their functions, with a significant focus on technology finance [4] - Valuations and institutional holdings in the securities sector are currently low, suggesting potential opportunities for growth [4] Insurance - The recent adjustments in LPR and deposit rates are expected to lower the cost of liabilities for insurance companies, which may enhance their operational quality [5] - The insurance sector is projected to experience a decline in new business value growth compared to 2024, but overall operational quality is expected to improve [5] Recommended and Benefiting Stocks - Recommended stocks include Jiangsu Jinzhong, Hong Kong Stock Exchange, and China Pacific Insurance [6] - Benefiting stocks include Guosen Securities, Jiufang Zhitu Holdings, and China Galaxy Securities [6]

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Viewpoints - The Hong Kong Stock Exchange is expected to benefit from the expansion of the asset side, with an increase in trading activity due to leading A-share companies listing in Hong Kong and quality Chinese concept stocks returning to the Hong Kong market [3][4] - The report highlights the recent relaxation of regulations regarding securities firms' private placements, with a focus on financing for sectors related to the real economy [4] - The insurance sector is anticipated to see a reduction in liability costs due to the recent decrease in LPR and deposit rates, which may lead to a further decline in the preset interest rates for insurance products [5] Summary by Sections Non-Bank Financial - The report indicates a positive outlook for the non-bank financial sector, with a focus on the benefits from the expansion of the asset side in the Hong Kong market [3][4] Securities Firms - The average daily trading volume for stock funds was 1.31 trillion, a decrease of 5.6% week-on-week, but a year-on-year increase of 50% [4] - The China Securities Association is developing a special evaluation method for securities firms, emphasizing support for technology-driven enterprises [4] - The report suggests that the valuation of the securities sector is currently low, and there are opportunities for growth due to continued macroeconomic support for the stock market [4] Insurance - The recent adjustments in LPR and deposit rates are expected to lower the cost of liabilities for insurance companies, potentially leading to improved operational quality [5] - The report anticipates a decline in new business value growth compared to 2024, but an overall improvement in operational quality is expected [5] Recommended and Beneficiary Stocks - Recommended stocks include Jiangsu Jinzhong, Hong Kong Stock Exchange, and China Pacific Insurance [6] - Beneficiary stocks include Guosen Securities, Jiufang Zhitu Holdings, and China Galaxy Securities [6]

Investment Rating - The report maintains a "Recommended" rating for the insurance industry, indicating a potential increase of over 15% relative to the benchmark index [6]. Core Insights - The insurance industry has shown signs of recovery, with total premium income for the first four months of 2025 reaching CNY 25,955 billion, a year-on-year increase of 2.3%. The premium income for April alone was CNY 4,210 billion, up 9.6% year-on-year [3]. - Life insurance has transitioned to positive growth, driven by the launch of dividend and annuity products in April, alongside a shift in distribution channels towards long-term savings products. Health insurance, while experiencing short-term fluctuations, is expected to maintain long-term growth [4]. - The property insurance sector has benefited from increased auto sales, with premiums from auto insurance and non-auto insurance reaching CNY 2,967 billion and CNY 3,519 billion respectively in the first four months of 2025, reflecting year-on-year growth of 4.3% and 5.9% [5]. Summary by Sections Life Insurance - Life insurance premiums for January to April 2025 totaled CNY 16,061 billion, a year-on-year increase of 1.2%. In April, the premium income was CNY 2,229 billion, up 16.8% year-on-year [4]. - The health insurance segment reported premiums of CNY 3,255 billion for the first four months, with a slight year-on-year increase of 2.4%. However, April saw a decline of 2.9% year-on-year [4]. Investment Products - New contributions to policyholder investment funds showed signs of recovery, with total contributions of CNY 3,076 billion from January to April, down 4.8% year-on-year, but April alone saw a 16.3% increase [5]. - The independent accounts of investment-linked insurance products reported stable contributions of CNY 49 billion, indicating a need for improved market conditions to enhance customer risk appetite [5]. Property Insurance - The property insurance sector's performance was bolstered by strong auto sales, with total premiums reaching CNY 2,967 billion for auto insurance and CNY 3,519 billion for non-auto insurance in the first four months of 2025 [5]. - The report highlights that the growth in non-auto insurance was primarily driven by liability, health, and accident insurance, with April premiums increasing by 8.9%, 14.7%, and 27.8% respectively [5]. Future Outlook - The report anticipates that life insurance will gradually emerge from its adjustment phase, focusing on high-quality development in a low-interest-rate environment. Property insurance will aim for a balance between scale and value [7]. - Investment suggestions include focusing on companies like China Pacific Insurance, New China Life, China Life, Ping An Insurance, Sunshine Insurance, and China Property Insurance, which are expected to benefit from improving product structures and market conditions [7].

Group 1 - The core viewpoint emphasizes the importance of rural revitalization through industry, livelihood, and talent support, with a focus on sustainable development in Yunnan Province [3][4] - The company has invested 404,200 yuan in 2024 to support the full industrial chain of black-boned chickens, benefiting over 800 farmers and generating 38,000 yuan in collective dividends [2] - A total of 12 skill training sessions were organized, covering 280 participants and cultivating 37 leading figures in wealth creation [2] Group 2 - The company has conducted 21 environmental sanitation activities and visited 126 underprivileged individuals to promote the construction of beautiful and livable villages [2] - The company plans to introduce deep processing enterprises and expand e-commerce sales channels to enhance the sustainable development of local agricultural products [4] - A collaborative mechanism of "insurance + meteorology + emergency" will be established to provide customized risk management services for new agricultural entities [4]

保险资金长期投资改革试点落地又有新进展。 资事堂获悉：平安资产管理有限责任公司获国家金管总局正式批复，同意设立恒毅持盈(深圳)私募基金 管理有限公司（以下简称"恒毅持盈私募"）。 目前，鸿鹄私募正在推进第三期资金的落地。 据悉，恒毅持盈未来将作为基金管理人向平安人寿定向发行契约型私募证券投资基金，首期基金规模 300亿元。基金将聚焦"长期投资、价值投资"的理念，重点布局符合政策导向和险资配置需要的优质上 市公司，积极发挥保险资金耐心资本的优势，助力中国资本市场高质量发展。 而恒毅持盈私募，刷新了单家险资"出资入市"的规模。 险资"长钱"已超2000亿元 过去一年多的时间里，险资纷纷成立私募机构，搭建了险资"长期"入市国内权益市场的新通道。 2024年一季度，中国人寿、新华保险联合创立鸿鹄私募，成为险资长期股票投资试点的首批成员。鸿鹄 一期规模为500亿元人民币，投资方向是具有较大市值、流动性好以及较高市场影响力的优质上市公 司。 2025年5月，新华保险公告出资100亿元认购国丰兴华鸿鹄志远二期私募证券投资基金（以下简称"鸿鹄 基金二期"）的份额。 鸿鹄基金二期仍为新华保险与中国人寿出资。 据悉，恒毅持盈将作 ...

保险资金长期投资改革试点落地有新进展。 日前，平安资产管理有限责任公司正式获批设立恒毅持盈 (深圳）私募基金管理有限公司（下称"恒毅持 盈"），并于5月30日完成工商登记。 据了解，恒毅持盈将作为基金管理人向平安人寿定向发行契约型私募证券投资基金，首期基金规模300亿元。 基金将聚焦"长期投资、价值投资"的理念，重点布局符合政策导向和险资配置需要的优质上市公司。 保险资金长期投资改革试点，指的是保险公司出资设立私募证券基金，主要投向二级市场股票，并长期持有。 今年3月，金融监管总局批复5家保险公司开展长期投资改革试点，平安人寿是试点公司之一。 天眼查显示，恒毅持盈注册资本3亿元，法定代表人窦泽云，许可经营项目包括，私募证券投资基金管理服务 等（须在中国证券投资基金业协会完成登记备案后方可从事经营活动）。 今年3月，中国平安总经理兼联席首席执行官谢永林接受券商中国记者专访时曾谈及该试点，其表示，长期股 票投资试点政策打通了中长期资金入市的卡点堵点，为险资提供良好的投资环境，平安将积极配合国家政策， 推动险资入市。 谢永林认为，险资入市将带来多方共赢，既有利于改善资本市场资金供给结构，也可帮助企业获取长期稳定 的 ...

Core Viewpoint - China Life Insurance (02628.HK) is currently in a steady upward channel, with short-term support levels at HKD 15.50 and HKD 14.60, and resistance levels set at HKD 16.60 and HKD 17.00. The overall upward probability is 52%, indicating conditions for continued upward movement [1]. Technical Analysis - The stock price has stabilized above all major moving averages, including the 10-day moving average at HKD 15.80, the 30-day moving average at HKD 14.92, and the 60-day moving average at HKD 15.10, forming a bullish structure [1]. - The trading volume reached HKD 621 million, providing substantial financial support for the stock's rise and reflecting increased market participation [1]. - The RSI index is currently at 68, indicating strong bullish sentiment, while the Williams and Stochastic indicators are in the overbought zone but have not shown clear signs of weakening [1]. - The CCI and psychological line indicators are also leaning bullish, with momentum and volatility indicators supporting the current upward trend [1]. - The Bollinger Bands show the stock is approaching the upper band, with MACD and Ichimoku indicators simultaneously issuing buy signals, indicating a strong overall trend [1]. Signal Summary - The technical indicators for China Life Insurance have been summarized as a "strong buy," achieving a perfect score of 16, indicating multiple technical factors are resonating to support the stock's continued rise [3]. - Since May 20, the stock has consistently received "buy" to "strong buy" ratings, with clear market trends and active participation from major funds [3]. Derivative Products Performance - On May 26, when the underlying stock rose by 2.17%, related derivative products showed even more impressive gains, with Morgan Stanley's bull certificate (68142) leading with a 13% increase, followed by Citibank's call warrants (25657 and 25498) with increases of 12% and 11%, respectively [3]. Investment Products - For bullish strategies, Societe Generale's call warrant (15787) and Citibank's call warrant (15987) offer approximately 6.5 times leverage, with exercise prices around HKD 17.3 [6]. - Citibank's bull certificate (54112) provides a 6.1 times actual leverage with a recovery price of HKD 13.5, offering a higher safety margin for bullish investors [6]. - For bearish strategies, UBS's put warrant (14199) and Morgan Stanley's put warrant (13914) provide about 5.7 times leverage, both with exercise prices of HKD 13.88 [6]. - Citibank's bear certificate (57271) stands out with 8.3 times high leverage and the lowest premium, while UBS's bear certificate (57555) offers 6.7 times actual leverage [6]. Overall Market Outlook - China Life Insurance exhibits strong characteristics across various technical parameters, and if it can maintain the support level of HKD 15.50, it is expected to challenge the resistance levels of HKD 16.60 and HKD 17.00 [7]. - Despite some short-term indicators being at high levels, as long as trading volume and momentum remain healthy, there is still room for upward movement [7].

在监管层持续鼓励长期资金入市的背景下，继2023年10月中国人寿和新华保险成为首批险资长期投资试点机构 后， 2025年，险资长期投资试点持续扩容，第二批试点机构已增至8家，而规模达600亿元的第三批试点机构也在 陆续获批中。 长期投资试点不断扩容 备案信息显示，泰康稳行成立于今年4月21日，于2025年5月26日完成私募证券投资基金管理人备案登记。公司注 册于武汉，办公地在北京，注册资本为1000万元，由泰康资产全资控股。 泰康资产作为泰康保险集团旗下资产管理子公司，截至2024年末，管理资产总规模超4.2万亿元，其中受托管理的 第三方资产总规模超2.5万亿元。 高管团队方面，泰康稳行法定代表人、执行董事王琦此前是泰康资产权益投资部股票投资执行总监。总经理刘志 强此前是泰康资产权益投资部投资经理。二人均具有20多年金融从业经历。在加入泰康资产之前，王琦曾先后供 职于大通证券、中关村证券、中信建投证券及中信建投基金等机构。刘志强则曾任职于平安保险和嘉实基金等机 构，其自2008年7月加入泰康资产至今已有17年。 "设立泰康稳行管理该试点基金，旨在响应保险资金长期投资改革试点，进一步增加符合保险资金投资策略的长 ...

Group 1 - The 19th "GuoShou 616" Customer Festival of China Life officially launched on May 30, focusing on the theme "Smartly Protecting Life with China Life" and emphasizing intelligent technology and comprehensive financial product services [1] - The festival will last for one month, featuring online and offline activities, including a "Super Experience Day" on June 16, and special events for important occasions such as the Dragon Boat Festival, Children's Day, Father's Day, and the high school entrance examination [1] - China Life will showcase nearly 20 high-quality financial products across its insurance, investment, and banking sectors, addressing diverse customer needs through an integrated online and offline experience [1] Group 2 - During the customer festival, China Life will enhance its comprehensive financial capabilities by sharing service resources, collaborating with star customers, and coordinating elderly care services, thereby innovating and upgrading its collaborative model [2] - The company aims to provide a convenient and reliable one-stop comprehensive financial service experience by increasing the supply of integrated financial products and services [2]

Core Insights - The 2025 "Shenzhen Huimin Bao" has been officially launched, maintaining a premium of 88 yuan while upgrading coverage, serving as an important supplement to Shenzhen's multi-level medical insurance system [1] - Since its introduction in 2023, "Shenzhen Huimin Bao" has enrolled over 12.13 million participants, covering nearly half of Shenzhen's permanent population, effectively addressing diverse medical insurance needs and reducing out-of-pocket expenses for residents [1] - China Life Insurance Company has been the chief underwriter for three consecutive years, contributing to product design, service optimization, and operational management, leading to significant improvements in coverage and service quality [1] Summary by Categories Premium and Coverage Adjustments - The 2025 "Shenzhen Huimin Bao" employs a strategy of "five reductions, three expansions, and one increase" to optimize coverage [2] - The deductibles for the five benefit categories have been reduced by 4,000 yuan, with a maximum reduction of 28.6%, and an additional 1,000 yuan reduction for participants with two or more years of coverage [2] Expanded Benefits - The program has broadened the scope of inpatient self-paid coverage, rare disease special treatment, and the "Hong Kong and Macau drug and device" coverage [2] - The annual cap for rare disease medications has been increased to 600,000 yuan, and the coverage for "Hong Kong and Macau drug and device" has been expanded to 17 items, with a maximum reimbursement of 500,000 yuan per year [2] Inclusion of Expatriates - For the first time, "Shenzhen Huimin Bao" includes Shenzhen residents with medical insurance in other regions, allowing them to benefit from the program after reimbursing compliant medical expenses through their local insurance [2] Digital Transformation - China Life's Shenzhen branch has actively promoted digital ecosystem development, achieving a 99% claim rate through a "one-stop" service, significantly reducing the financial burden on insured individuals [2]